Oxford-AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign.

Adverse effects AstraZeneca vaccine COVID-19 COVID-19 vaccine Vaccine campaign

Journal

Public health
ISSN: 1476-5616
Titre abrégé: Public Health
Pays: Netherlands
ID NLM: 0376507

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 23 04 2021
accepted: 25 05 2021
pubmed: 2 7 2021
medline: 20 8 2021
entrez: 1 7 2021
Statut: ppublish

Résumé

A strong COVID-19 vaccine campaign is needed to reach the herd immunity and reduce this pandemic infection. In the Foch Hospital, France, in February 2021, 451 healthcare workers were vaccinated by a first dose of AstraZeneca vaccine. Adverse effects were reported to our pharmaco-vigilance circuit, by an online and anonymous questionnaire following the first weeks of the vaccinal campaign to healthcare workers. Two hundred seventy-four (60.8%) of them reported multiple adverse effects. Main adverse effects reported were feverish state/chills (65.7%), fatigue/physical discomfort (62.4%), arthralgia/muscle pain (61.0%) and fever (44.5%). On March 2021 many European countries suspended AstraZeneca vaccine for one week due to safety uncertainty. Thus, confidence in its efficacy is undermined. However, the benefit/risk balance is clearly in favor of vaccination.

Identifiants

pubmed: 34198072
pii: S0033-3506(21)00220-1
doi: 10.1016/j.puhe.2021.05.030
pmc: PMC8169320
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

135-137

Informations de copyright

Copyright © 2021 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Références

Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
Semin Hematol. 2007 Apr;44(2):62-9
pubmed: 17433897
Lancet. 2020 Nov 21;396(10263):1614-1616
pubmed: 33159850
BMJ. 2021 Mar 19;372:n774
pubmed: 33741638
Nat Rev Immunol. 2020 Oct;20(10):583-584
pubmed: 32908300
Lancet. 2021 Mar 6;397(10277):881-891
pubmed: 33617777
Lancet Public Health. 2021 Apr;6(4):e210-e221
pubmed: 33556325
Chaos. 2021 Apr;31(4):041105
pubmed: 34251248

Auteurs

A Vallée (A)

Department of Clinical Research and Innovation, Foch Hospital, Suresnes, France. Electronic address: alexandre.g.vallee@gmail.com.

A Chan-Hew-Wai (A)

Hospital Pharmacy, Foch Hospital, Suresnes, France.

B Bonan (B)

Hospital Pharmacy, Foch Hospital, Suresnes, France.

P Lesprit (P)

Department of Hygiene and Infectious Disease, Foch Hospital, Suresnes, France.

F Parquin (F)

Intensive Respiratory Care Department, Foch Hospital, Suresnes, France.

É Catherinot (É)

Department of Pneumology, Foch Hospital, Suresnes, France.

J Choucair (J)

Department of Pneumology, Foch Hospital, Suresnes, France.

D Billard (D)

Department of Oncology, Foch Hospital, Suresnes, France.

C Amiel-Taieb (C)

Department of Occupational Health, Foch Hospital, Suresnes, France.

È Camps (È)

Hospital Pharmacy, Foch Hospital, Suresnes, France.

C Cerf (C)

Department of Intensive Care, Foch Hospital, Suresnes, France.

D Zucman (D)

Department of Internal Medicine, Réseau Ville Hôpital Val de Seine, Foch Hospital, Suresnes, France.

E Fourn (E)

Department of Internal Medicine, Réseau Ville Hôpital Val de Seine, Foch Hospital, Suresnes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH